Emerging treatment options to improve cardiovascular outcomes in patients with acute coronary syndrome: focus on losmapimod

Each year, despite optimal use of recommended acute and secondary prevention therapies, 4%–5% of patients with acute coronary syndrome (ACS) experience relapse of ACS or other cardiovascular events including stroke, heart failure, or sudden cardiac death after the index ACS. The sudden atherosclerot...

Descripción completa

Detalles Bibliográficos
Autores principales: Kragholm, Kristian, Newby, Laura Kristin, Melloni, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532348/
https://www.ncbi.nlm.nih.gov/pubmed/26273189
http://dx.doi.org/10.2147/DDDT.S69546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532348/
https://www.ncbi.nlm.nih.gov/pubmed/26273189
http://dx.doi.org/10.2147/DDDT.S69546

Ejemplares similares